News

Shares of several biotech firms fell in premarket trading Monday after reports that ousted U.S. Food and Drug Administration ...
Alnylam Pharma raised its revenue outlook as its heart drug sees quick uptake.
Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...
Biotech firm aims to streamline operations and reinvest in high-growth areas such as oncology and rare diseases as it targets ...
Moderna announced layoffs affecting 10% of its workforce amid government and competitive challenges to its vaccine business ...
The U.S. Food and Drug Administration has granted full approval for Moderna's MRNA.O COVID-19 vaccine, Spikevax, in children ...
The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval to those with at least one underlying condition that puts them at risk ...
Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease Written by moderna inc.